Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

NCT05715931 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Adenocarcinoma of the Stomach
Adenocarcinoma of Esophagogastric Junction
HER2-positive Gastric Cancer

Interventions

DRUG: Toripalimab
DRUG: Trastuzumab
DRUG: 5-FU, leucovorin, docetaxel, oxaliplatin (FLOT)

Sponsor

Yu jiren